Eton Pharmaceuticals (ETON) Other Operating Expenses (2021)

Eton Pharmaceuticals (ETON) reported Other Operating Expenses of $181000.0 for Q2 2021.

Eton Pharmaceuticals (ETON) Other Operating Expenses (2021) Analysis & Trends

Eton Pharmaceuticals (ETON) has 1 years of Other Operating Expenses data on file, last reported at $181000.0 in Q2 2021.

For the quarter ending Q2 2021, Other Operating Expenses changed N/A year-over-year to $181000.0; the trailing twelve-month figure through Mar 2022 stood at $181000.0 (changed N/A YoY), and the FY2021 full-year result was $181000.0, changed N/A from the prior year.
Other Operating Expenses steadied at $181000.0 in Q2 2021.
In the past five years, Other Operating Expenses ranged from a high of $181000.0 in Q2 2021 to a low of $181000.0 in Q2 2021.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Eton Pharmaceuticals	1.19 Bn	1.16 Bn	13.10 Mn

Historic Data

Download Data

Date	Value
Jun 30, 2021	181,000.00